Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fibrin matrix scaffold is a naturally occurring or bioengineered network made primarily of cross-linked fibrin protein, formed from fibrinogen by thrombin during blood clotting. It provides a temporary, highly biocompatible and biodegradable extracellular matrix for cells. In tissue engineering, the scaffold allows for cell migration, adhesion, proliferation, and differentiation, facilitating the repair, regrowth, or substitution of damaged or defective tissues. Fibrin scaffolds can be modified with other biopolymers or chemically cross-linked to improve mechanical properties and degradation rates, and may be used as carriers for stem cells or therapeutic agents. They are broadly used in regenerative therapies for skin, nerve, bone, and organ tissue engineering and have vital roles in wound healing and hemostasis.
Promotes cell migration and tissue ingrowth by providing a biocompatible, biodegradable scaffold Serves as a carrier for cells or bioactive molecules/drugs Controls release of factors (antibiotics, growth factors) loaded into the scaffold Can be modified to control degradation rates and mechanical stability
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin matrix scaffold (None).